Back to search

Article

Toward “off‐the‐shelf” allogeneic CAR T cells

2020-04-30

Abstract excerpt

Chimeric antigen receptor (CAR) T cell therapy represents a major breakthrough in the field of immuno-oncology. Many potential issues are apparent for autologous CAR T cell therapy, such as time for manufacturing and need for interim therapies in progressing patients, wide variations in terms of quality and quantity of T cells, and difficulty to obtain enough cells for redosing. “Off-the-shelf” allogeneic CAR T ce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
484b7dfa-c27c-52e5-ac0a-950669f17120
DOI
10.1002/acg2.86
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Toward “off‐the‐shelf” allogeneic CAR T cellsDOI 10.1002/acg2.86
Select a neighboring publication to make it the new centre.